Browse by category

Outcomes from the BARI-OPTIMISE randomised clinical trial, which assessed 24 weeks of liraglutide (3.0mg) as an adjunct to a lifestyle...

Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Once-weekly subcutaneous semaglutide (2.4mg) is more effective on weight loss in conjunction with counselling and physical activity vs...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a licence extension for Saxenda (Novo Nordisk) for the...

Researchers at UT Southwestern have reported that the weight-loss drug once-daily liraglutide combined with lifestyle interventions can...

Researchers at University of Copenhagen and Hvidovre Hospital who examined four different types of treatment following a diet-induced...

A preclinical study from the Perelman School of Medicine at the University of Pennsylvania, has shown how the weight loss drug,...

Intensive behavioural therapy (IBT) combined with liraglutide 3.0mg (Saxenda) can produce clinically-meaningful weight loss in patients...